Yabby and Myriota launch IoT dam sensing solition

Satellite communications company Myriota and water management company Yabby Sensors and Consulting have launched a nanosatellite Internet of Things (IoT) solution for the mining and agricultural sector. Their system provides dam operators and owners with an automatic dam and water storage monitoring solution, allowing them to identify and manage safety, regulatory and water use issues.…

Creating Australian sovereign vaccine capability – by Julie Phillips

Julie Phillips leads a group attempting to save from closure one of Australia’s largest pharmaceutical plants and repurpose it to produce Covid-19 vaccines. Here she explains that with Covid-19 not going away anytime soon, now is the time to act and create new capabilities. GSK‘s largest southern hemisphere pharmaceutical and vaccine manufacturing plant in Boronia,…

Fibres and composites transforming industry – boron nitride nanotubes

@AuManufacturing’s editorial series – fibres and composites transforming industry – turns today to the latest wonder material – boron nitride nanotubes. Will BNNT’s be the wonder material that makes the real breakthrough from science to widespread practical use? By Peter Roberts Wonder fibres and composites come and go, sometimes like carbon fibre nanotubes finding an…

Lockheed and Thales muscle in on Australian missile manufacturing opportunity

Two of the world’s largest defence contractors, Lockheed Martin and Thales, have joined forces to compete for the opportunity of building an Australian missile manufacturing facility for the federal government. Defence recently began a smart procurement process to select the group that will develop an Australian Guided Weapons Enterprise under a $1 billion federal government…

One door closes, a vaccine future opens for GSK’s Melbourne pharma plant

By Peter Roberts The announcement that the Victorian government will back a new mRNA vaccine production facility with $50 million has offered new hope to the giant GSK pharmaceutical operation at Boronia in eastern Melbourne which has been slated for closure by the global group. With GSK re-directing its businesses towards biopharmaceuticals it has no…